Sanofi Reports Dupixent Sales Surge by 158% to €1.377 Billion in First Nine Months of 2019

Text | Baihuawen

On October 30, Sanofi announced its financial results for the first three quarters of 2019, with sales revenue reaching €26.518 billion, a year-on-year increase of 2.2%. Among them, the sales revenue in the third quarter was €9.499 billion, a year-on-year decrease of 1.1%.

Sanofi’s Core Drug Sales in the First Three Quarters of 2019 (€ billion)